Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of tumor complexity

World Journal of Clinical Oncology

Volumn 5, Issue 5, 2014, Pages 901-907

  Lamberti, María Julia ^a   Rumie Vittar, Natalia Belén ^a   Rivarola, Viviana Alicia ^a  

^a DEPARTAMENTO DE QUÍMICA   (Argentina)

Author keywords

Breast cancer; Photodynamic therapy; Synergism; Treatment combination; Tumor microenvironment

Indexed keywords

EID: 84942587947     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v5.i5.901     Document Type: Article

References (49)

1. Ponka J, Latocha M. [Photodynamic therapy in the treatment of breast cancer]. Pol Merkur Lekarski 2012; 33: 173-175 [PMID: 23157138]
2. Master A, Livingston M, Sen Gupta A. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release 2013; 168: 88-102 [PMID: 23474028 DOI: 10.1016/j.jconrel.2013.02.020]
3. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61: 250-281 [PMID: 21617154 DOI: 10.3322/caac.20114]
4. Mang TS, Allison R, Hewson G, Snider W, Moskowitz R. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am 1998; 4: 378-384 [PMID: 9853137]
5. Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV. Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett 2012; 326: 8-16 [PMID: 22842096 DOI: 10.1016/j.canlet.2012.07.026]
6. National Cancer Institute/National Institute of Health. Breast Cancer Treatment (PDQ®). Available from: URL: http: //www.cancer.gov/cancertopics/pdq/treatment/breast/Patient/page5 2013
7. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006; 58: 621-681 [PMID: 16968952]
8. Schaffer M, Schaffer PM, Corti L, Gardiman M, Sotti G, Hofstetter A, Jori G, Dühmke E. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model. J Photochem Photobiol B 2002; 66: 157-164 [PMID: 11960724 DOI: 10.1016/S1011-1344(02)00237-3]
9. Berg K, Luksiene Z, Moan J, Ma L. Combined treatment of ionizing radiation and photosensitization by 5-aminolevulinic acid-induced protoporphyrin IX. Radiat Res 1995; 142: 340-346 [PMID: 7761584]
10. Montazerabadi AR, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Aledavood A. The effects of combined treatment with ionizing radiation and indocyanine green-mediated photodynamic therapy on breast cancer cells. J Photochem Photobiol B 2012; 109: 42-49 [PMID: 22325306 DOI: 10.1016/j.jphotobiol.2012.01.004]
11. Ara G, Varshney A, Ha CS, Oseroff AR, Herman TS, Teicher BA. Multiple modality treatment of carcinoma cells with Pt(Rh-123)2 plus x-ray plus light. Photochem Photobiol 1992; 55: 561-567 [PMID: 1620732 DOI: 10.1111/j.1751-1097.1992. tb04278.x]
12. Dobler-Girdziunaite D, Burkard W, Haller U, Larsson B, Walt H. [The combined use of photodynamic therapy with ionizing radiation on breast carcinoma cells in vitro]. Strahlenther Onkol 1995; 171: 622-629 [PMID: 7502225]
13. Crescenzi E, Varriale L, Iovino M, Chiaviello A, Veneziani BM, Palumbo G. Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol Cancer Ther 2004; 3: 537-544 [PMID: 15141011]
14. Zimmermann A, Walt H, Haller U, Baas P, Klein SD. Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient. Cancer Chemother Pharmacol 2003; 51: 147-154 [PMID: 12647016 DOI: 10.1007/s00280-002-0549-9]
15. Tong ZS, Miao PT, Liu TT, Jia YS, Liu XD. Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin on breast cancer in mice. Acta Pharmacol Sin 2012; 33: 1319-1324 [PMID: 22842729]
16. Lamberti MJ, Vittar NB, da Silva Fde C, Ferreira VF, Rivarola VA. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1). Phytomedicine 2013; 20: 1007-1012 [PMID: 23746950 DOI: 10.1016/j.phymed.2013.04.018]
17. Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 2009; 16: 97-110 [PMID: 19211237 DOI: 10.1016/j.phymed.200 8.12.018]Available]
18. Oude Munnink TH, Nagengast WB, Brouwers AH, Schröder CP, Hospers GA, Lub-de Hooge MN, van der Wall E, van Diest PJ, de Vries EG. Molecular imaging of breast cancer. Breast 2009; 18 Suppl 3: S66-S73 [PMID: 19914546 DOI: 10.1016/S0960-9776(09)70276-0]
19. James DA, Swamy N, Paz N, Hanson RN, Ray R. Synthesis and estrogen receptor binding affinity of a porphyrin-estradiol conjugate for targeted photodynamic therapy of cancer. Bioorg Med Chem Lett 1999; 9: 2379-2384 [PMID: 10476873 DOI: 10.1016/S0960-894X(99)00390-X]
20. Swamy N, James DA, Mohr SC, Hanson RN, Ray R. An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells. Bioorg Med Chem 2002; 10: 3237-3243 [PMID: 12150869 DOI: 10.1016/S0968-0896(02)00242-0]
21. Fernandez Gacio A, Fernandez-Marcos C, Swamy N, Dunn D, Ray R. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate. J Cell Biochem 2006; 99: 665-670 [PMID: 16795032 DOI: 10.1002/jcb.20932]
22. El-Akra N, Noirot A, Faye JC, Souchard JP. Synthesis of estradiol-pheophorbide a conjugates: evidence of nuclear targeting, DNA damage and improved photodynamic activity in human breast cancer and vascular endothelial cells. Photochem Photobiol Sci 2006; 5: 996-999 [PMID: 17077894 DOI: 10.1039/B606117F]
23. Sadler S, Persons KS, Jones GB, Ray R. Internalization of a C17α-alkynylestradiol-porphyrin conjugate into estrogen receptor positive MCF-7 breast cancer cells. Bioorg Med Chem Lett 2011; 21: 4638-4641 [PMID: 21704522 DOI: 10.1016/j.bmcl.2011.05.094]
24. Swamy N, Purohit A, Fernandez-Gacio A, Jones GB, Ray R. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate. J Cell Biochem 2006; 99: 966-977 [PMID: 16741968 DOI: 10.1002/jcb.20955]
25. Savellano MD, Pogue BW, Hoopes PJ, Vitetta ES, Paulsen KD. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates. Cancer Res 2005; 65: 6371-6379 [PMID: 16024640 DOI: 10.1158/0008-5472. CAN-05-0426]
26. Bhatti M, Yahioglu G, Milgrom LR, Garcia-Maya M, Chester KA, Deonarain MP. Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments. Int J Cancer 2008; 122: 1155-1163 [PMID: 17973256 DOI: 10.1002/ijc.23206]
27. Stuchinskaya T, Moreno M, Cook MJ, Edwards DR, Russell DA. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochem Photobiol Sci 2011; 10: 822-831 [PMID: 21455532 DOI: 10.1039/c1pp05014a]
28. Hu Z, Rao B, Chen S, Duanmu J. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice. BMC Cancer 2010; 10: 235 [PMID: 20504328 DOI: 10.1186/1471-2407-10-235]
29. Duanmu J, Cheng J, Xu J, Booth CJ, Hu Z. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy. Br J Cancer 2011; 104: 1401-1409 [PMID: 21427724 DOI: 10.1038/bjc.2011.88]
30. Xu P, Chen J, Chen Z, Zhou S, Hu P, Chen X, Huang M. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity. PLoS One 2012; 7: e37051 [PMID: 22693566 DOI: 10.1371/journal.pone.0037051]
31. Rahimipour S, Ben-Aroya N, Ziv K, Chen A, Fridkin M, Koch Y. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues. J Med Chem 2003; 46: 3965-3974 [PMID: 12954050 DOI: 10.1021/jm020535y]
32. Gijsens A, Missiaen L, Merlevede W, de Witte P. Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity. Cancer Res 2000; 60: 2197-2202 [PMID: 10786684]
33. Cogno IS, Vittar NB, Lamberti MJ, Rivarola VA. Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells. J Photochem Photobiol B 2011; 104: 434-443 [PMID: 21641815 DOI: 10.1016/j.jphotobiol.2011.05.001]
34. Ferenc P, Solár P, Kleban J, Mikes J, Fedorocko P. Downregulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells. J Photochem Photobiol B 2010; 98: 25-34 [PMID: 19932626 DOI: 10.1016/j.jphotobiol.2009.10.004]
35. Liu W, Baer MR, Bowman MJ, Pera P, Zheng X, Morgan J, Pandey RA, Oseroff AR. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2. Clin Cancer Res 2007; 13: 2463-2470 [PMID: 17438106 DOI: 10.1158/1078-0432.CCR-06-1599]
36. Vinogradov S, Wei X. Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond) 2012; 7: 597-615 [PMID: 22471722 DOI: 10.2217/nnm.12.22]
37. Selbo PK, Weyergang A, Eng MS, Bostad M, Mælandsmo GM, Høgset A, Berg K. Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug. J Control Release 2012; 159: 197-203 [PMID: 22349185 DOI: 10.1016/j.jconrel.2012.02.003]
38. Goler-Baron V, Assaraf YG. Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics. PLoS One 2012; 7: e35487 [PMID: 22530032 DOI: 10.1371/journal. pone.0035487]
39. Niziolek M, Korytowski W, Girotti AW. Nitric oxideinduced resistance to lethal photooxidative damage in a breast tumor cell line. Free Radic Biol Med 2006; 40: 1323-1331 [PMID: 16631522 DOI: 10.1016/j.freeradbiomed.2005.11.022]
40. Bhowmick R, Girotti AW. Signaling events in apoptotic photokilling of 5-aminolevulinic acid-treated tumor cells: inhibitory effects of nitric oxide. Free Radic Biol Med 2009; 47: 731-740 [PMID: 19524035 DOI: 10.1016/j.freeradbiomed.200 9.06.009]
41. Bhowmick R, Girotti AW. Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acidbased photodynamic therapy. Free Radic Biol Med 2010; 48: 1296-1301 [PMID: 20138143 DOI: 10.1016/j.freeradbiomed.2 010.01.040]
42. Bhowmick R, Girotti AW. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress. Free Radic Biol Med 2013; 57: 39-48 [PMID: 23261943 DOI: 10.1016/j.freeradbiomed. 2012.12.005]
43. Rumie Vittar NB, Lamberti MJ, Pansa MF, Vera RE, Rodriguez ME, Cogno IS, Milla Sanabria LN, Rivarola VA. Ecological photodynamic therapy: new trend to disrupt the intricate networks within tumor ecosystem. Biochim Biophys Acta 2013; 1835: 86-99 [PMID: 23127970 DOI: 10.1016/j.bbcan.2012.10.004]
44. Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 2011; 12: 551-564 [PMID: 21860391 DOI: 10.1038/nrm3176]
45. Thomas N, Pernot M, Vanderesse R, Becuwe P, Kamarulzaman E, Da Silva D, François A, Frochot C, Guillemin F, Barberi-Heyob M. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties. Biochem Pharmacol 2010; 80: 226-235 [PMID: 20380812 DOI: 10.1016/j.bcp.2010.03.036]
46. Xia Y, Gupta G, Castano A, Mroz P, Avci P, Hamblin M. CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer. J Biophotonics 2013; In press [PMID: 23922221 DOI: 10.1002/jbio.201300072]
47. Wyld L, Tomlinson M, Reed MW, Brown NJ. Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation. Br J Cancer 2002; 86: 1343-1347 [PMID: 11953896 DOI: 10.1038/sj.bjc.6600234]
48. Friberg EG, Cunderlíková B, Pettersen EO, Moan J. pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer. Cancer Lett 2003; 195: 73-80 [PMID: 12767514 DOI: 10.1016/S0304-3835(03)00150-2]
49. Jain RK, Shah SA, Finney PL. Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia. J Natl Cancer Inst 1984; 73: 429-436 [PMID: 6589435]